Cambridge Neuropsychological Testing Automated Battery
The Cambridge Neuropsychological Testing Automated Battery (CANTAB) is a neuropsychological measure developed at the University of Cambridge and currently marketed by Cambridge Cognition Limited (CCL). The CANTAB is a theoretically derived instrument, predominantly measuring nonlanguage functions including memory, executive function, attention, decision-making, and social cognition. The current versions are validated for use online and by the use of tablet technology. A tablet-based memory screening device labeled CANTAB Mobile was recently awarded FDA clearance to be marketed as a medical devise in USA. CANTAB tests are described as having sufficient sensitivity to discern changes in cognitive functioning brought about by CNS disorders and medications. The publisher regards performance on CANTAB tests to be independent of language and culture.
Originally created in the late 1980s to diagnose dementia in elderly individuals (Fray et al....
References and Readings
- Luciana, M. (2003). Practitioner review: Computerized assessment of neuropsychological function in children: Clinical and research applications of the Cambridge Neuropsychological Testing Automated Battery (CANTAB). Journal of Child Psychology and Psychiatry, 44(5), 649–663.PubMedCrossRefGoogle Scholar